SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 107 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $419,276 | -52.3% | 108,340 | -26.5% | 0.00% | – |
Q2 2023 | $878,444 | +64.8% | 147,390 | -9.6% | 0.00% | – |
Q1 2023 | $533,151 | -60.5% | 163,043 | -52.3% | 0.00% | -100.0% |
Q4 2022 | $1,350,403 | +276.2% | 341,874 | +471.4% | 0.00% | – |
Q3 2022 | $359,000 | -75.4% | 59,833 | -73.6% | 0.00% | -100.0% |
Q2 2022 | $1,460,000 | -42.6% | 226,999 | -26.3% | 0.00% | 0.0% |
Q1 2022 | $2,543,000 | +48.0% | 307,811 | +177.4% | 0.00% | – |
Q4 2021 | $1,718,000 | +38.7% | 110,967 | +101.7% | 0.00% | – |
Q3 2021 | $1,239,000 | +628.8% | 55,005 | +536.8% | 0.00% | – |
Q2 2021 | $170,000 | +11.1% | 8,638 | +89.8% | 0.00% | – |
Q1 2021 | $153,000 | – | 4,552 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 34,239,018 | $530,020,000 | 8.19% |
Crestline Management, LP | 3,210,937 | $49,705,000 | 3.71% |
SB Management Ltd | 2,209,004 | $34,195,000 | 3.38% |
Omega Fund Management, LLC | 843,750 | $13,061,000 | 1.85% |
Alphabet Inc. | 2,812,500 | $43,538,000 | 1.05% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 387,508 | $5,999,000 | 0.84% |
HARVARD MANAGEMENT CO INC | 468,749 | $7,256,000 | 0.68% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,131,249 | $63,952,000 | 0.34% |
Dragoneer Investment Group | 1,500,000 | $23,220,000 | 0.27% |
Artal Group S.A. | 400,000 | $6,192,000 | 0.17% |